$AVNS

BLACKFORD GARY sold (to issuer) $2.0M of AVNS

BLACKFORD GARY sold (to issuer) 79,590 shares of AVANOS MEDICAL, INC. (AVNS) at $25.00 ($1.99M total) on 2026-07-27.

Original reporting
SEC EDGAR · BLACKFORD GARY
Published Jul 28, 2026, 9:35 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 28, 2026, 9:40 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$AVNS
Neutral
high confidence
Mentioned
$AVNS
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AVNSNeutralLow
01

Why it matters

The newest fact is the director’s sale of 79,590 shares at $25.00/share to the issuer, with holdings reduced to 0 shares; no other company-specific news is included.

02

Market read

Primarily a compliance disclosure; it may slightly affect sentiment but does not provide new operational or financial information.

03

What to watch

The transaction is coded as sale to issuer, which often reflects structured buyback participation rather than a discretionary bearish bet.

Relevance 6/10Novelty 3/10Timing: Filed on 2026-07-28, covering a sale dated 2026-07-27.

Background

The article is an SEC Form 4 insider transaction disclosure for Avanos Medical, Inc. (AVNS).

Company-level read

Ticker impact

$AVNSNeutralHigh confidence
Context

Avanos Medical director Gary Blackford sold 79,590 shares to the issuer for $25.00/share, leaving 0 shares after the transaction.

Expected impact

Low likelihood of a sustained price move; any reaction would likely be muted and short-lived.

Evidence & confidence

The filing is a Form 4 insider transaction with no 10b5-1 plan and no accompanying operational or guidance change disclosed in the text.

Market effects

No sector read-across is provided; this is company-specific insider transaction disclosure.

None indicated.

None indicated.

Counterpoint

Insider sales can sometimes precede negative developments, but this filing lacks any stated reason or linkage to new company events.

Key entities

  • AVANOS MEDICAL, INC.

    Company whose director insider sale to the issuer is disclosed on Form 4.

  • BLACKFORD GARY

    Director who sold 79,590 shares to the issuer on 2026-07-27.

Related articles

$AVNSLow

AVANOS MEDICAL, INC. (AVNS): Completion of Acquisition or Disposition of Assets

AVANOS MEDICAL, INC. (AVNS) filed an SEC Form 8-K — Completion of Acquisition or Disposition of Assets. EX-10.1 4 avnsform8k_07272026xex101.htm EX-10.1 Document Execution Version CREDIT AGREEMENT dated as of July 27, 2026 among A-AV MERGERSUB, INC., as the Initial Borrower, AVANOS MEDICAL, INC., as the Borrower Representative, A-AV ACQUIRECO, INC., as a Borrower, A-AV INTERMEDIATEC